5.4 million people in the UK are currently receiving treatment for asthma. The UK has some of the highest prevalence rates in Western Europe and on average 3 people a day die from asthma. Despite its prevalence, 1 in 2 asthma patients do not have their asthma well controlled.

In 2015, Asthma UK began working with a range of partners from across Europe on a three-year study to develop a novel sensor-based inhaler, myAirCoach, which connects to a patients’ smart device and monitors a range of physiological, behavioural and environmental factors. It aims to help asthma patients to self-manage and increase their awareness of their clinical and environmental state. It will also create a new and more comprehensive dataset of the biological state of people’s asthma on a day-to-day basis. This can then be examined by researchers who are aiming to discover whether asthma exacerbations can be predicted and treated at an earlier stage. The project will build evidence about the potential for mobile Health to manage asthma and other long-term conditions.

MyAirCoach is a ground-breaking project that will pave the way for more effective management of asthma based on real-time data from the patient and their environment. The use of a wide array of information will help to predict a worsening in asthma symptoms, such that treatment can be subsequently adjusted to avert a life-threatening asthma attack. Researcher perspective